市场调查报告书
商品编码
1288649
全球近视和老花眼治疗市场研究报告 - 行业分析、规模、份额、增长、趋势和2023至2030年预测Global Myopia and Presbyopia Treatment Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030 |
据推测,到2030年,全球近视和老花眼治疗市场的需求将从2022年的28.92亿美元达到近77.78亿美元,在2023-2030年的研究期间,复合年增长率为11.62%。
近视和老花是两种需要治疗的常见视力状况。近视,也被称为近视,是一种远处的物体看起来很模糊的状况。另一方面,老花眼是一种随着人的年龄增长,眼睛逐渐失去聚焦于附近物体的能力的状况。
由于生活习惯的改变和人口老龄化,近视和老花眼的发病率在全球范围内不断增加。这正在推动对有效治疗方案的需求。新的手术技术、隐形眼镜和药品的发展正在推动市场的增长。患者和医疗机构对现有的近视和老花眼的治疗方案的认识越来越多。这导致了对治疗方案的更大需求,推动了市场的增长。在治疗近视和老花眼方面,微创手术的需求量很大。这是由于这种手术的好处,包括更快的恢复时间和减少并发症的风险。医疗保健支出的增加,特别是在新兴经济体,正在推动近视和老花眼治疗市场的增长。随着这些国家的医疗系统不断扩大和改善,更多的患者获得了治疗方案。
该研究报告包括波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清楚地了解行业结构,并在全球范围内评估竞争的吸引力。此外,这些工具还对全球近视和老花眼治疗市场的每个细分市场进行了全面评估。近视和老花眼治疗行业的增长和趋势为这项研究提供了一个全面的方法。
本节涵盖了区域前景,强调了北美、欧洲、亚太、拉美、中东和非洲的近视和老花眼治疗市场的当前和未来需求。此外,该报告重点关注所有突出地区的个别应用部门的需求、估计和预测。
该研究报告还涵盖了市场中主要参与者的全面概况和对全球竞争格局的深入看法。近视和老花眼治疗市场的主要参与者包括Ziemer Ophthalmic Systems AG, NIDEK CO.LTD., Johnson & Johnson Vision, Essilor Ltd., Zeiss International, ALCON VISION LLC, Bausch & Lomb Incorporated., Carl Zeiss AG, Orasis Pharmaceuticals, Regeneron Pharmaceuticals Inc., Haag-Streit UK, Topcon Corporation, AbbVie, Sydnexis, The Cooper Companies Inc.这一部分包括对竞争格局的整体看法,其中包括各种战略发展,如主要的合并和收购、未来的能力、伙伴关系、财务概况、合作、新产品的开发、新产品的推出以及其他发展。
注意 - 在公司简介中,财务细节和最近的发展情况要视情况而定,如果是私营公司,可能不包括在内。
The global demand for Myopia and Presbyopia Treatment Market is presumed to reach the market size of nearly USD 77.78 BN by 2030 from USD 28.92 BN in 2022 with a CAGR of 11.62% under the study period 2023-2030.
Myopia and presbyopia are two common vision conditions that require treatment. Myopia, also known as nearsightedness, is a condition in which objects that far away appear blurry. Presbyopia, on the other hand, is a condition in which the eye gradually loses its ability to focus on nearby objects as a person ages.
The prevalence of myopia and presbyopia is increasing worldwide due to changing lifestyle habits and an ageing population. This is driving the demand for effective treatment options. The development of new surgical techniques, contact lenses, and pharmaceuticals is driving the growth of the market. There is a growing awareness among patients and healthcare providers about the available treatment options for myopia and presbyopia. This is leading to greater demand for treatment options and driving the growth of the market. Minimally invasive procedures are in demand for the treatment of myopia and presbyopia. This is due to the benefits of such procedures, including faster recovery times and reduced risk of complications. The increasing healthcare expenditure, particularly in emerging economies, is driving the growth of myopia and presbyopia treatment market. As healthcare systems continue to expand and improve in these countries, more patients are gaining access to treatment options.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of myopia and presbyopia treatment. The growth and trends of myopia and presbyopia treatment industry provide a holistic approach to this study.
This section of the myopia and presbyopia treatment market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
This section covers the regional outlook, which accentuates current and future demand for the Myopia and Presbyopia Treatment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the myopia and presbyopia treatment market include Ziemer Ophthalmic Systems AG, NIDEK CO. LTD., Johnson & Johnson Vision, Essilor Ltd., Zeiss International, ALCON VISION LLC, Bausch & Lomb Incorporated., Carl Zeiss AG, Orasis Pharmaceuticals, Regeneron Pharmaceuticals Inc., Haag-Streit UK, Topcon Corporation, AbbVie, Sydnexis, The Cooper Companies Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.